A randomized comparison of low-molecular-weight heparin (enoxaparin) and unfractionated heparin adjunctive to t-PA thrombolysis and aspirin (HART-II)

被引:0
|
作者
Molhoek, GP
Knudtson, M
Lundergan, CF
de Jong, E
Schwartz, W
Coyne, K
Draoui, Y
Regalado, L
Ross, AM
机构
[1] Medisch Spectrum Twente, Enschede, Netherlands
[2] Foothills Hosp, Calgary, AB T2N 2T9, Canada
[3] George Washington Univ, Washington, DC USA
[4] Aventis, Collegeville, PA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3269
引用
收藏
页码:600 / 600
页数:1
相关论文
共 50 条
  • [21] A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease
    Cohen, M
    Demers, C
    Gurfinkel, EP
    Turpie, AGG
    Fromell, GJ
    Goodman, S
    Langer, A
    Califf, RM
    Fox, KAA
    Premmereur, J
    Bigonzi, F
    NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (07): : 447 - 452
  • [22] Is unfractionated heparin equivalent to low-molecular-weight heparin for venous thromboemblism?
    Graber, Mark A.
    Dachs, Robert
    Darby-Stewart, Andrea
    AMERICAN FAMILY PHYSICIAN, 2008, 77 (11) : 1492 - 1493
  • [23] BEHAVIOR OF UNFRACTIONATED HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARIN IN RAT ORGANISM
    KHLGATIAN, SV
    UMAROVA, BA
    SHAPIRO, FB
    STRUKOVA, SM
    DOKLADY AKADEMII NAUK SSSR, 1990, 313 (02): : 509 - 511
  • [24] Pharmacokinetic and pharmacodynamic properties of eptifibatide in healthy subjects receiving unfractionated heparin or the low-molecular-weight heparin enoxaparin
    Gretler, DD
    CLINICAL THERAPEUTICS, 2003, 25 (10) : 2564 - 2574
  • [25] Low-molecular-weight Heparin (enoxaparin) versus unfractionated heparin for venous thromboembolism prophylaxis in patients undergoing craniotomy
    Kandula, Viswajit
    Shah, Parth, V
    Thirunavu, Vineeth M.
    Yerneni, Ketan
    Karras, Constantine
    Abecassis, Zachary A.
    Hopkins, Benjamin
    Bloch, Orin
    Potts, Matthew B.
    Jahromi, Babak S.
    Tate, Matthew C.
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2022, 223
  • [26] IS ANTICOAGULATION WITH LOW-MOLECULAR-WEIGHT HEPARIN SUPERIOR TO UNFRACTIONATED HEPARIN IN HEMODIALYSIS
    LAUBENTHAL, F
    PLUM, J
    SPRENGER, KBG
    GRABENSEE, B
    NIEREN-UND HOCHDRUCKKRANKHEITEN, 1989, 18 (11) : 488 - 493
  • [27] The effects of unfractionated heparin and low-molecular-weight heparin on platelet activation
    Cui, Wei
    Lu, Jing-chao
    Guo, Nan
    Liu, Fan
    Xie, Rui-qin
    Gu, Guo-qiang
    Du, Jun
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (8A): : 195M - 195M
  • [28] Heparin and low-molecular-weight heparin therapy for venous thromboembolism: Will unfractionated heparin survive?
    Hull, RD
    Pineo, GF
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2004, 30 : 11 - 23
  • [29] EFFECTS OF STANDARD HEPARIN AND A LOW-MOLECULAR-WEIGHT HEPARIN (KABI-2165) ON PLASMA-LEVEL OF T-PA AND PA INHIBITOR
    AGNELLI, G
    BORM, J
    COSMI, I
    LEVI, M
    TENCATE, JW
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 17 - 17
  • [30] Comparison of low-molecular-weight heparin and unfractionated heparin for venous thromboembolism prophylaxis in trauma patients
    Gowler, Aimee
    Erstad, Brian
    Tang, Andrew
    PHARMACOTHERAPY, 2013, 33 (05): : E52 - E52